+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Spontaneous in vitro maturation of oocytes prior to ovarian tissue cryopreservation in natural cycles of oncologic patients



Spontaneous in vitro maturation of oocytes prior to ovarian tissue cryopreservation in natural cycles of oncologic patients



Journal of Assisted Reproduction and Genetics 29(11): 1261-1265



To evaluate the recovery rate and spontaneous in vitro maturation (IVM) of immature oocytes enclosed within or released from follicles during the processing of ovarian tissue prior to its cryopreservation. Thirty-three oncologic patients who had not previously undergone chemo or radiotherapy underwent ovarian tissue cryopreservation (OTC) during natural menstrual cycles. Immature oocytes, enclosed within follicles or released during ovarian cortex processing, were collected and matured spontaneously in vitro for 48 h. Nuclear maturation was assessed every 24 h and the ability of the IVM oocytes to display a normal activation response following parthenogenetic activation was evaluated. The following outcome measures were also evaluated: disease, age, FSH, LH, E2, P4 and AMH serum levels, menstrual cycle day, recovery and spontaneous IVM and parthenogenetic activation rates. Oocytes recovered per patient were 3.3 ± 0.7 (1.8-4.7 oocytes, 95CI), regardless of the menstrual phase. The mean number of IVM oocytes per patient was 1.3 ± 0.2 oocytes (95CI: 0.8-1.8), regardless of menstrual phase (p = 0.86) and oocyte origin (p = 0.61). Forty-one percent of oocytes extruded the second polar body and formed one pronucleus after parthenogenetic activation. Twenty-one of the 33 women (63.6 %) requesting OTC produced at least one mature oocyte.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055889698

Download citation: RISBibTeXText

PMID: 22965314

DOI: 10.1007/s10815-012-9860-5


Related references

In-vitro maturation of germinal-vesicle oocytes and cryopreservation in metaphase I/II: a possible additional option to preserve fertility during ovarian tissue cryopreservation. Reproductive Biomedicine Online 8(5): 553-557, 2004

Methodological problems and clinical advantage of cryopreservation of ovarian tissue as well as in vitro maturation of follicles and oocytes. Molecular & Cellular Endocrinology 164(1-2): 270, 2000

Cryopreservation/transplantation of ovarian tissue and in vitro maturation of follicles and oocytes: challenges for fertility preservation. Reproductive Biology and Endocrinology 6: 47, 2008

Live birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryo cryopreservation for 5 years. Fertility and Sterility 104(5): 1258-1260, 2015

In vitro maturation is an efficient technique to generate oocytes and should be considered in combination with cryopreservation of ovarian tissue for preservation of fertility in women. Journal of Clinical Oncology 24(33): 5336-7; Author Reply 5337-8, 2006

Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer. Journal of Assisted Reproduction and Genetics 29(8): 779-781, 2012

In vitro maturation and cryopreservation of oocytes retrieved from intra-operative aspiration during second enucleation for ovarian tumor: A case report. Gynecologic Oncology Reports 19: 1-4, 2017

Spontaneous in vitro maturation and artificial activation of human germinal vesicle oocytes recovered from stimulated cycles. Journal of Assisted Reproduction and Genetics 28(2): 111-117, 2011

Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes. Journal of Ovarian Research 7: 80, 2014

Rescue in vitro maturation (IVM) of immature oocytes in stimulated cycles in women with low functional ovarian reserve (LFOR). Endocrine 52(1): 165-171, 2016

Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy. Human Reproduction 31(4): 750-762, 2016

Combined strategy for fertility preservation in an oncologic patient: vitrification of in vitro matured oocytes and ovarian tissue freezing. Journal of Assisted Reproduction and Genetics 28(12): 1147-1149, 2011

Vitrification of in vitro matured oocytes collected from antral follicles at the time of ovarian tissue cryopreservation. Reproductive Biology and Endocrinology 9: 150, 2011

Improving ovarian tissue cryopreservation for oncologic patients: slow freezing versus vitrification, effect of different procedures and devices. Fertility and Sterility 101(3): 775-784, 2014

Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome: Case Report. Human Reproduction 23(2): 336-339, 2008